Invest in Surface Oncology Inc on Stash
Surface Oncology, Inc is a clinical-stage immuno-oncology company
SURF Performance Breakdown
Share Price
$1.07
Today's change
-0.93%
Year to date change (YTD)
30.49%
Dividend yield
N/A
Last dividend paid
N/A
Last dividend pay date
N/A
About SURF
Surface Oncology, Inc. is a clinical-stage immuno-oncology company. The Company is engaged in the development of cancer immunotherapies. To unlock the potential of cancer immunotherapy, the Company is targeting a set of immune processes by which cancer cells evade immune recognition and attack. Its programs are built upon insights about how to improve the immune systemís recognition and elimination of cancer cells. These include approaches to improve the effectiveness of antigen presentation to the adaptive immune system, to block the activity of a range of suppressor cells in the tumor microenvironment, and to counter the immunosuppressive environment that selectively accumulates in and around the tumor. By targeting the interface of innate and adaptive immunity, it hopes to expand the reach of cancer immunotherapy to patients in need of treatment.
Surface Oncology Inc Stock Ticker
SURF
For more information
Certain companies are volatile
Certain companies can be volatile, meaning the stock price fluctuates significantly. Don’t put all your eggs into one basket and remember to keep the Stash Way in mind when you invest.
Surface Oncology Inc stock news
Why invest with Stash?
Fractional shares
Thousands of stocks and ETFs. No investing minimums.
Unlimited trades
Plus no add-on trading commission fees.†
Diversification analysis
Custom investment recommendations can help you diversify.
Automatic investing
Dividend reinvestment,8 recurring investments, and more.
The Stock-Back® Card
We’ll give you matching stock in companies you shop at.1
Learn how to invest
Get professional advice and education at every step.
How to buy Surface Oncology Inc stock on Stash
Stash allows you to purchase smaller, more affordable pieces of investments (called fractional shares) rather than the whole share, which can be significantly more expensive.
Stash offers one subscription plan: The Stash Plan.
Once your market order of Surface Oncology Inc stock is complete, you'll officially be a shareholder of Surface Oncology Inc!
More Health Care stocks
Karyopharm Therapeutics, Inc.
10.88%
Absci Corporation
10.36%
Alamar Biosciences, Inc.
9.61%
Veradermics, Incorporated
8.68%
Charles River Laboratories International
8.31%
Latigo Biotherapeutics, Inc.
7.67%
Pacific Biosciences of California, Inc.
7.65%
GRAIL Inc.
7.5%
Nautilus Biotechnology, Inc
7.06%
Liquidia Technologies Inc
6.48%
Twist Bioscience Corp.
6.19%



